Business segment information

3 Months Ended

Mar. 31, 2025

Business segment information

Business segment information

Note 2 – Business segment information:

		% controlled at
Business segment	Entity	March 31, 2025
Chemicals	Kronos	81%
Component products	CompX	87%
Real estate management and development	BMI and LandWell	63% - 77%

Our control of Kronos includes approximately 50% we hold directly and approximately 31% held directly by NL. We own approximately 83% of NL. Our control of CompX is through NL. We own approximately 63% of BMI. Our control of LandWell includes the approximately 27% we hold directly and 50% held by BMI.

Our chief operating decision maker (“CODM”) evaluates segment performance based on each segment’s operating income, which is defined as income before income taxes and interest expense, exclusive of certain non-recurring items (such as gains or losses on disposition of business units and other long-lived assets outside the ordinary course of business and certain legal settlements) and certain general corporate income and expense items (including securities transactions gains and losses and interest and dividend income), which are not attributable to the operations of the reportable operating segments. Interest income included in the calculation of segment operating income is not significant for the three months ended March 31, 2024 or 2025.

	Three months ended
	March 31,
	2024		2025
	(In millions)
Net sales:
Chemicals	$	478.8	$	489.8
Component products		38.0		40.3
Real estate management and development		13.8		8.5
Total net sales	$	530.6	$	538.6
Cost of sales:
Chemicals	$	407.9	$	383.4
Component products		28.3		28.1
Real estate management and development		8.1		4.6
Total cost of sales	$	444.3	$	416.1
Gross margin:
Chemicals	$	70.9	$	106.4
Component products		9.7		12.2
Real estate management and development		5.7		3.9
Total gross margin	$	86.3	$	122.5
Operating income:
Chemicals	$	22.8	$	41.2
Component products		3.7		5.9
Real estate management and development		5.0		3.0
Total operating income		31.5		50.1
General corporate items:
Interest income and other		5.7		4.3
Other components of net periodic pension and OPEB expense		(.6)		(.8)
Changes in market value of Valhi common stock held by subsidiaries		.5		(1.7)
General expenses, net		(7.8)		(7.9)
Interest expense		(11.3)		(13.2)
Income before income taxes	$	18.0	$	30.8

	Three months ended
	March 31,
	2024		2025
	(In millions)
Depreciation and amortization:
Chemicals	$	11.5	$	14.4
Component products		.9		1.0
Real estate management and development		.1		—
Total	$	12.5	$	15.4

Segment results we report may differ from amounts separately reported by our various subsidiaries due to purchase accounting adjustments and related amortization or differences in the way we define operating income. Intersegment sales are not material. Our CODM is not regularly provided financial information related to the assets of the reportable segments, including capital expenditures, and he does not evaluate their performance or allocate resources to them based on assets. Therefore, total assets by reportable segment are not included in our segment disclosures.